Study of XIAP Antisense for Advanced Cancers

Clinical trial NCT00385775 · TERMINATED

Trial details

NCT number: NCT00385775
Sponsor: Aegera Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2006-06-01
Primary completion: 2008-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.